Cell type-specific disruption of cortico-striatal circuitry drive repetitive patterns of behaviour in fragile X syndrome model mice
Francesco LongoiD, Sameer AryaliD, Paul G. AnastasiadesiD, Marta MalteseiD, Corey BaimeliD, Federica AlbaneseiD, Joanna Tabor, Jeffrey D. ZhuiD, Mauricio Martins OliveiraiD, Denise GastaldoiD, Claudia BagniiD, Emanuela SantiniiD, Nicolas X. TritschiD, Adam G. CarteriD, Eric KlanniD
Abstract
Individuals with fragile X syndrome (FXS) are frequently diagnosed with autism spectrum disorder (ASD), including increased risk for restricted and repetitive behaviours (RRBs). Consistent with observations in humans, FXS model mice display distinct RRBs and hyperactivity that are consistent with dysfunctional cortico-striatal circuits, an area relatively unexplored in FXS. Using a multidisciplinary approach, we dissected the contribution of two populations of striatal medium spiny neurons (SPNs) in the expression of RRBs in FXS model mice. We found that dysregulated protein synthesis at cortico-striatal synapses is a molecular culprit of the synaptic and ASD-associated motor phenotypes displayed by FXS model mice. Cell-type-specific translational profiling of the FXS mouse striatum revealed differentially translated mRNAs, providing critical information concerning potential therapeutic targets. Our findings represent the first evidence of a cell-type specific impact of the loss of FMRP on translation and the sequence of neuronal events in the striatum that drive RRBs in FXS. HighlightsDysregulated striatal protein synthesis underlies altered synaptic plasticity and RRBs displayed by FXS model mice FXS model mice exhibit cell type-specific molecular, morphological, and synaptic changes in the dorsolateral striatum Selective deletion of Fmr1 from dSNPs in mice alters translation and causes repetitive behavior TRAP-Seq indicates that there is altered binding of >120 mRNAs to ribosomes in dSNPs of Fmr1 KO mice G-protein signaling (RGS) 4 translation is significantly reduced in dSPNs in FXS model mice Treatment of FXS model mice with VU0152100, a positive allosteric modulator of the M4 muscarinic receptor that is upstream of RGS4, can reverse RRBs
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tilted striatofugal balance and beneficial effects of facilitating mGlu4 receptor activity in the Fmr1-/- mouse model of Fragile X Syndrome
Mathieu Fonteneau, Claire Terrier, … Julie Le Merrer·Pharmacological ResearchPeer-reviewed·Oct 28, 2026
- Late onset of striatal projection neuron hyperexcitability in Fmr1-/y mice
Lars Nelson, Michael Janeček, … Rui T. Peixoto·bioRxiv·Jun 21, 2025
- Astroglial FMRP modulates synaptic signaling and behavior phenotypes in FXS mouse model
Shan‐Xue Jin, Haruki Higashimori, … Yongjie Yang·GliaPeer-reviewed·Sep 24, 2020
- Vorinostat corrects cognitive and non-cognitive symptoms in a mouse model of fragile X syndrome
Qi Ding, Xueting Wu, … Hongbing Wang·The International Journal of NeuropsychopharmacologyPeer-reviewed·Nov 12, 2021
- Translational modulation by ISRIB alleviates synaptic and behavioral phenotypes in Fragile X syndrome
Rochelle L. Coulson, Valentina Frattini, … Gordon X. Wang·bioRxiv·Sep 8, 2023
- FMR1 Perturbations Disrupt Sensory Corticostriatal Circuits and Mitochondrial Energetics in Fragile X Syndrome
Yu Yan, Dongyun Li, … Minjie Shen·bioRxiv·Oct 11, 2026